Recent Developments in the Design of Orally Bioavailable &bgr;3-Adrenergic Receptor Agonists

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|13|1|25-37

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.13, Iss.1, 2006-01, pp. : 25-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Saccharomyces cerevisiae GSK-3&bgr; Homologs

By  

Current Drug Targets, Vol. 7, Iss. 11, 2006-11 ,pp. : 1455-1465

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Progress in the Field of &bgr;-(1,3)-Glucans and New Applications

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 12, 2006-12 ,pp. : 1341-1349

Bentham Science Publishers

Access to resources Recommend Favorite

&bgr;3-Adrenergic Receptors: Really Relevant Targets for Anti-Obesity Drugs?

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 3, Iss. 3, 2003-09 ,pp. : 257-273

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in Asthma and COPD Treatment: Combination Therapy with Inhaled Corticosteroids and Long-Acting &bgr;2-Agonists.

By  

Current Pharmaceutical Design, Vol. 12, Iss. 25, 2006-01 ,pp. : 3261-3279

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of &bgr;2-Adrenergic Receptors in Inflammation and Allergy

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 2, 2005-04 ,pp. : 157-162

Bentham Science Publishers

Access to resources Recommend Favorite